RGEN Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 11, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Repligen Corp (RGEN)

Based on 28 analysts giving stock ratings to Repligen Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
57
Hold
18
Sell
0
Strong Sell
0
Repligen Corp

Repligen Corp. Stock Analysis RGEN

United States Health Care Mid Cap Report:
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Read More

Repligen Corp (RGEN) Chart

Key Statistics of Repligen Corp (RGEN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$102.55$107.75

Today's Open

$104.46

Volume

2.31M

P/E Ratio (TTM)

135.19

52 Week Range

$100.99$175.77

Market Cap

7.08B

Avg. Volume

1.24M

Dividend Yield

-

Financial Metrics & Statements of Repligen Corp (RGEN)

Community-Curated Collections with Repligen Corp (RGEN) ( With RGEN )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Repligen Corp (RGEN)

  • According to Musaffa’s Shariah screening methodology, Repligen Corp (RGEN) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.